Literature DB >> 10642232

Risk assessment of left ventricular systolic dysfunction in primary care: cross sectional study evaluating a range of diagnostic tests.

O W Nielsen1, J F Hansen, J Hilden, C T Larsen, J Svanegaard.   

Abstract

OBJECTIVES: To assess the probability of left ventricular systolic dysfunction without echocardiography in patients from general practice.
DESIGN: Cross sectional study using multivariate regression models to examine the relation between clinical variables and left ventricular systolic dysfunction as determined by echocardiography.
SETTING: Three general practices in Copenhagen.
SUBJECTS: 2158 patients aged >40 years were screened by questionnaires and case record reviews; 357 patients with past or present signs or symptoms of heart disease were identified, of whom 126 were eligible for and consented to examination. MAIN OUTCOME MEASURES: Clinical variables that were significantly (P<0.05) related to ejection fraction </=0.45 and their predictive value for left ventricular systolic dysfunction.
RESULTS: 15 patients (12%) had left ventricular systolic dysfunction. The prevalence was significantly related to three questions: does the electrocardiogram have Q waves, left bundle branch block, or ST-T segment changes? (P=0.012); is resting supine heart rate greater than the simultaneous diastolic blood pressure? (P=0.002); and is plasma N-terminal atrial natriuretic peptide>0.8 nmol/l? (P=0.040)? Only one of 60 patients with a normal electrocardiogram had systolic dysfunction (2%, 95% confidence interval 0% to 9%) regardless of response to the other two questions. The risk of dysfunction was appreciable in patients with a yes answer to two or three questions (50%, 27% to 73%).
CONCLUSIONS: A normal electrocardiogram implies a low risk of left ventricular systolic dysfunction. Patients can be identified for echocardiography on the basis of an abnormal electrocardiogram combined with increased natriuretic peptide concentration or a heart rate greater than diastolic blood pressure, or both.

Entities:  

Mesh:

Year:  2000        PMID: 10642232      PMCID: PMC27270          DOI: 10.1136/bmj.320.7229.220

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  21 in total

1.  Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population.

Authors:  T A McDonagh; C E Morrison; A Lawrence; I Ford; H Tunstall-Pedoe; J J McMurray; H J Dargie
Journal:  Lancet       Date:  1997-09-20       Impact factor: 79.321

2.  Simplified echocardiography in the diagnosis of heart failure.

Authors:  R B Willenheimer; B A Israelsson; C M Cline; L R Erhardt
Journal:  Scand Cardiovasc J       Date:  1997       Impact factor: 1.589

3.  Usefulness of echocardiography in detecting left ventricular dysfunction in population-based studies (The Rotterdam Study).

Authors:  A Mosterd; M C de Bruijne; A W Hoes; J W Deckers; A Hofman; D E Grobbee
Journal:  Am J Cardiol       Date:  1997-01-01       Impact factor: 2.778

4.  Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.

Authors:  D J Sahn; A DeMaria; J Kisslo; A Weyman
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690

5.  Cross sectional study of contribution of clinical assessment and simple cardiac investigations to diagnosis of left ventricular systolic dysfunction in patients admitted with acute dyspnoea.

Authors:  N D Gillespie; G McNeill; T Pringle; S Ogston; A D Struthers; S D Pringle
Journal:  BMJ       Date:  1997-03-29

6.  Biochemical detection of left-ventricular systolic dysfunction.

Authors:  T A McDonagh; S D Robb; D R Murdoch; J J Morton; I Ford; C E Morrison; H Tunstall-Pedoe; J J McMurray; H J Dargie
Journal:  Lancet       Date:  1998-01-03       Impact factor: 79.321

7.  Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

Authors:  M R Bristow; E M Gilbert; W T Abraham; K F Adams; M B Fowler; R E Hershberger; S H Kubo; K A Narahara; H Ingersoll; S Krueger; S Young; N Shusterman
Journal:  Circulation       Date:  1996-12-01       Impact factor: 29.690

8.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.

Authors: 
Journal:  Lancet       Date:  1999-01-02       Impact factor: 79.321

9.  Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care.

Authors:  S J McClure; L Caruana; A P Davie; S Goldthorp; J J McMurray
Journal:  BMJ       Date:  1998-08-22

10.  Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care.

Authors:  M R Cowie; A D Struthers; D A Wood; A J Coats; S G Thompson; P A Poole-Wilson; G C Sutton
Journal:  Lancet       Date:  1997-11-08       Impact factor: 79.321

View more
  25 in total

1.  Predicting left ventricular systolic dysfunction. Combining test results gives best predictive effect.

Authors:  F Dobbs
Journal:  BMJ       Date:  2000-10-07

2.  Taking heart failure seriously.

Authors:  J G Cleland; A Clark; J L Caplin
Journal:  BMJ       Date:  2000-11-04

3.  Docetaxel induced cardiotoxicity.

Authors:  M Shimoyama; Y Murata; K I Sumi; R Hamazoe; I Komuro
Journal:  Heart       Date:  2001-08       Impact factor: 5.994

4.  Strong prognostic value of combining N-terminal atrial natriuretic peptide and ECG to predict death in heart patients from general practice.

Authors:  O W Nielsen; J Hilden; J F Hansen
Journal:  Heart       Date:  2001-08       Impact factor: 5.994

5.  Implementation of the NICE guidelines for the primary prevention of mortality from ventricular tachyarrhythmias: implications for UK electrophysiology centres; activity modelling from the UK-HEART study.

Authors:  N P Gall; M T Kearney; A Zaman; S O'Nunain; K A Fox; A Flapan; J Nolan
Journal:  Heart       Date:  2001-08       Impact factor: 5.994

6.  Renin angiotensin system inhibition is associated with reduced free radical concentrations in arteries of patients with coronary heart disease.

Authors:  C Berry; N Anderson; A J Kirk; A F Dominiczak; J J McMurray
Journal:  Heart       Date:  2001-08       Impact factor: 5.994

7.  Risk assessment of left ventricular systolic dysfunction in primary care. Drug treatment might be contaminating factor.

Authors:  R Kelly; A D Struthers
Journal:  BMJ       Date:  2000-07-08

8.  What happened to evidence in NICE guidance on heart failure?

Authors:  John Robson
Journal:  BMJ       Date:  2003-10-18

Review 9.  Basic transthoracic echocardiography.

Authors:  Graham S Hillis; Peter Bloomfield
Journal:  BMJ       Date:  2005-06-18

10.  Survival differences between heart failure in general practices and in hospitals.

Authors:  O Wendelboe Nielsen; J Hilden; T McDonagh; J Fischer Hansen
Journal:  Heart       Date:  2003-11       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.